3 Industries Most Likely to be Disrupted by Cannabidiol

December 16, 2019 09:00:31

If you have been paying even the slightest attention to the news for the past few years, you have undoubtedly heard of cannabidiol (CBD), the hemp extract that has taken the world by storm. For a product that was barely known 5 years ago, it has come a long way, with a market estimated to be worth billions.

Extremely potent and versatile, CBD is effective against an impressive list of conditions ranging from anxiety and depression to high blood pressure and chronic pain. In June last year, the U.S. Food and Drug Administration (FDA) approved a CBD derived drug to treat seizures in rare and hard to manage…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.